News

Special Sections

The Silver Series: The Start of a New Gold-Silver Cycle (Part 1 of 3)

The Silver Series: The Start of a New Gold-Silver Cycle (Part 1 of 3)

Visual Capitalist | Equities.com |

Outlining some key indicators that point to a coming gold-silver cycle in which exposure to hard assets may help to protect wealth.


Total S.A. is Becoming a Compelling Value Play

Lyn Alden | Equities.com |

Total S.A. and other high-quality commodity producers are becoming more attractive for value investors with a long-term investment style.


The Impossible Recession in the World’s Playground

Marin Katusa | Equities.com |

Lessons learned from the major recession in Switzerland in the 1970s.


The Hidden Agenda Behind Trump’s Greenland Dreams

Marin Katusa | Equities.com |

Greenland is just an extension of the US-China trade war.


New Scientific Publication Further Supports BioMark's Assay

TheNewswire | Equities.com |

Article published in Future Science OA on the predictive value and clinical significance of BioMark's assay.


Palladium: The Secret Weapon in Fighting Pollution

Visual Capitalist | Equities.com |

The rare metal is critical in reducing harmful emissions from gas-powered vehicles.


​The Hot LATAM Jurisdictions for Mining

Craig Dempsey | Equities.com |

Latin America remains a largely undiscovered region in many commercial contexts. Notably, those sectors built upon natural resources and technology have plenty of room for new and expanding businesses.


​Harvard Study Rejuvenates Cannabis’s Potential Role in Cancer Treatment

Stephen L Kanaval | Equities.com |

A recent study shows how cannabis has the potential to kill cancer cells.


The Gold Rush of 2019

Rodney Johnson | Equities.com |

As long as the US and China are trading tariffs and barbs, and global central banks are figuring out new ways to separate savers from their cash, I think gold will trade higher.


BioMark’s Liquid Biopsy Scientific Paper To Be Featured as Cover on Cancers' Upcoming Issue

TheNewswire | Equities.com |

Cancers is an international, peer-reviewed open access journal on oncology.


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Jorge Fernandez - iBlades

Equities.com's Sam Mitchell interview iBlades CEO, Jorge Fernandez